We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Researcher – Early Drug Development, Miltenyi Biotec
Caroline Brandes, M.Sc. Molecular Biomedicine, joined Miltenyi Biotec in 2019 as a researcher in the early-stage drug development group of Dominik Lock. Since then, Caroline Brandes has been developing novel CAR and TCR T cell technologies for cancer immunotherapy, as well as non-viral T cell engineering and manufacturing processes with a focus on electroporation-based and genome-editing techniques.
